Is NEGXF or BTI a better dividend investment in 2026?

NEGXF currently yields 4.52% with a 5% 5-year dividend growth rate. BTI yields 5.38% with 5% growth. The better choice depends on your goal: BTI offers higher current income.

What is the dividend yield difference between NEGXF and BTI?

NEGXF has a forward dividend yield of 4.52% ($0.01/share annually). BTI yields 5.38% ($3.15/share annually). The yield gap is 0.86 percentage points.

Home › Compare › NEGXF vs BTI

NEGXF vs BTI: Dividend Comparison 2026

NEGXF yields 4.52% · BTI yields 5.38%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BTI wins by $10.8K in total portfolio value

INVESTMENT

TIME HORIZON10 years

NEGXF

● Live price

4.52%

Share price

$0.27

Annual div

$0.01

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$26.9K

Annual income

$603.41

Full NEGXF calculator →

BTI

● Live price

5.38%

Share price

$58.47

Annual div

$3.15

5Y div CAGR

11.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$37.7K

Annual income

$2,786.64

Full BTI calculator →

Portfolio growth — NEGXF vs BTI

📍 BTI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NEGXF	BTI
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NEGXF + BTI cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NEGXF pays

BTI pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NEGXF

Annual income on $10K today (after 15% tax)

$383.99/yr

After 10yr DRIP, annual income (after tax)

$512.90/yr

BTI

Annual income on $10K today (after 15% tax)

$457.40/yr

After 10yr DRIP, annual income (after tax)

$2,368.64/yr

At 15% tax rate, BTI beats the other by $1,855.75/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NEGXF + BTI for your $10,000?

NEGXF: 50%BTI: 50%

100% BTI50/50100% NEGXF

Portfolio after 10yr

$32.3K

Annual income

$1,695.03/yr

Blended yield

5.25%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

NEGXF

No analyst data

Altman Z

1.1

Piotroski

5/9

BTI

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$40.00

-31.6% upside vs current

Range: $40.00 — $40.00

Altman Z

2.1

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NEGXF buys

BTI buys

No recent congressional trades found for NEGXF or BTI in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNEGXFBTI

Forward yield	4.52%	5.38% ✓
Annual dividend / share	$0.01	$3.15 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	11.3% ✓
Portfolio after 10y	$26.9K	$37.7K ✓
Annual income after 10y	$603.41	$2,786.64 ✓
Total dividends collected	$5.3K	$14.3K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples

Year-by-year: NEGXF vs BTI ($10,000, DRIP)

Year	NEGXF Portfolio	NEGXF Income/yr	BTI Portfolio	BTI Income/yr	Gap
1← crossover	$11,152	$451.75	$11,299	$598.92	$147.00 → BTI
2	$12,403	$470.82	$12,794	$703.91	$391.00 → BTI
3	$13,761	$489.40	$14,518	$829.07	$757.00 → BTI
4	$15,232	$507.45	$16,513	$978.64	$1.3K → BTI
5	$16,823	$524.93	$18,827	$1,157.84	$2.0K → BTI
6	$18,542	$541.84	$21,518	$1,373.12	$3.0K → BTI
7	$20,398	$558.15	$24,657	$1,632.46	$4.3K → BTI
8	$22,400	$573.85	$28,329	$1,945.74	$5.9K → BTI
9	$24,557	$588.94	$32,637	$2,325.33	$8.1K → BTI
10	$26,879	$603.41	$37,708	$2,786.64	$10.8K → BTI

NEGXF vs BTI: Complete Analysis 2026

NEGXF — Stock

NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers prescription drug claims; dental claims; and claims for the extended health benefits, as well as a health care spending account that provides an amount of money to an individual to pay for health or dental benefits. The company also offers individual and aggregate stop loss products; medical emergency and travel assistance insurance services; administrative services, including the collection and payment of premiums for life and LTD coverage, as well as a suite of reporting tools; Web claims submission services; direct deposit services; and ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.

Full NEGXF Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →

📬

Get this NEGXF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NEGXF vs SCHD NEGXF vs JEPI NEGXF vs O NEGXF vs KO NEGXF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.